For Sopharma AD this effort is another contribution to an excellent corporate governance file.
Creating a clear message and making a long story short.
Jump to navigation
Established, trusted brand with a 85+ year track record.
Leading domestic player with strong market position in Bulgaria, backed by competitive pricing and strong recognisable brands.
Strong presence and track record in high‐growth CIS markets, constantly expanding into new geographies.
Diversified product portfolio with own “phyto-based” products. Growth potential in introduction of existing key products on new markets and building pipeline.
Strong financial performance on key markets despite unfavourable macro coupled with superior profitability and strong balance sheet.
Leading producer and distributor, vertically integrated in one Group creating competitive advantage.
Further M&A potential for value creation – capability of M&A execution well proved in the past years.